#News

Covaxin For Kids? Bharat Biotech Says Stage 2/3 Trials Completed

Covaxin For Kids, COVID in fully vaccinated peopleThird COVID-19 Vaccine Dose, Johnson & Johnson’s Vaccine, Covid vaccine trial on children, viral shedding, comirnaty, Sanofi-GSK COVID-19 vaccine, COVID vaccine her immunity, Delta Plus Variant Escape Vaccines, Johnson and Johnson vaccine ,Johnson and Johnson vaccine ,Trials Of Covavax On Children, Janssen Vaccine, janssen-vaccine, Heart Inflammation Risk Warning, pfizer vaccine india ,Best COVID Vaccine, mRNA COVID-19 vaccine, Pfizer vaccine for children, Punjab Students Planning To Go Abroad ,vaccine free ,COVID-19 vaccine after effect Pfizer and BioNTech Vaccine For Children, COVID vaccine start working, Covaxin trials on children ,Two COVID-19 Vaccine Doses Same Day, Pfizer-BioNTech Vaccine For Adolescents, slot for COVID-19 vaccination ,Moderna Pfizer Turns Down States Vaccine,India-Pfizer ,vaccine for children ,Sputnik Light ,Delayed Second Pfizer COVID-19 Shot, Pfizer Vaccine, rare COVID vaccine side-effects, Biological E. Vaccine Candidate, valneva vaccine, woman hates needles , Pfizer Donates DrugsVaccination for pregnant women ,COVAXIN ,COVID-19 reinfection ,co-win ,vaccine registration ,COVID-19 Vaccine For Below 18 Years, Free COVID-19 Vaccination ,Covishield Vaccine Open Market Price, Free COVID-19 vaccine ,COVID19 Vaccination Phase 3 ,18 years above eligible ,Priority Vaccines For Journalists ,Sputnik V Vaccine ,anti-rabies vaccine ,double shots of covid-19 vaccine ,100-Year-Old Woman vaccinated ,Bollywood stars COVID-19 vaccine ,Germany suspends AstraZeneca, After effects of COVID-19 infection ,Oxford Vaccine Europe Ban, Johnson Vaccine
Covaxin For Kids? Bharat Biotech has reportedly completed the Phase II/III trials of Covaxin on children in the age group of 2-18 years. It is the company that has developed Covaxin, the leading vaccine of Indian origin and is set to submit the data on these trials to the Drugs Controller General Of India (DCGI) soon.

Along with this announcement, the company’s Chairman and managing director, Krishna Ella also stated on Tuesday, that trials in Phase II/III are completed. They will be sending the results to the DCGI by next week. She added that it was the exact same product as administered to the adults.

This statement was made on the sidelines of “Vanijya Saptah”. This was organised by the department of Union ministry of commerce & industry, directorate general of foreign trade, the government of Telangana and Pharmexcil. They were commemorating 75 years of Indian independence, showcasing the strength of India as an economic force and reinvigorating exports of Telangana.

Covaxin, similar to Covishield, is administered as a two-dose vaccine. It has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). According to the TOI report, as a part of Phase II and III trials, it was administered to 525 children, 28 days apart. Bharat Biotech had received the drug regulator’s approval to conduct the trials on children in May of this year.

In an earlier statement, Krishna Ella had said that if all goes well, the vaccine could be cleared for administration to children by October this year.  Meanwhile, India has reportedly crossed the 80 crore mark in the number of doses administered. The government is aiming to vaccinate the entire population by the end of this year.


Suggested Reading :

Are COVID Booster Shots Ethical? With Half The World Waiting For Its First Shot?

COVID-19 Vaccine And Menstruation, Study Suggests Link: Report

How Will COVID-19 Pandemic End? Here’s What We Know